[HTML][HTML] Peer Reviewed: COVID-19 Severity and Mortality Among Chronic Liver Disease Patients: A Systematic Review and Meta-Analysis
R Nagarajan, Y Krishnamoorthy, S Rajaa… - Preventing Chronic …, 2022 - ncbi.nlm.nih.gov
Methods We searched for studies reporting COVID-19 outcomes among CLD and non-CLD
patients in databases including Medline, EMBASE, ScienceDirect, Google Scholar, and …
patients in databases including Medline, EMBASE, ScienceDirect, Google Scholar, and …
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
T Marjot, CS Eberhardt, T Boettler, LS Belli… - Journal of …, 2022 - Elsevier
The COVID-19 pandemic has presented a serious challenge to the hepatology community,
particularly healthcare professionals and patients. While the rapid development of safe and …
particularly healthcare professionals and patients. While the rapid development of safe and …
Mendelian randomization analysis reveals no causal relationship between nonalcoholic fatty liver disease and severe COVID-19
J Li, A Tian, H Zhu, L Chen, J Wen, W Liu… - Clinical Gastroenterology …, 2022 - Elsevier
Background & Aims The coronavirus disease 2019 (COVID-19) pandemic has witnessed
more than 4.5 million deaths as of the time of writing. Whether nonalcoholic fatty liver …
more than 4.5 million deaths as of the time of writing. Whether nonalcoholic fatty liver …
Potential effects of coronaviruses on the liver: an update
X Wang, J Lei, Z Li, L Yan - Frontiers in Medicine, 2021 - frontiersin.org
The coronaviruses that cause notable diseases, namely, severe acute respiratory syndrome
(SARS), middle east respiratory syndrome (MERS) and coronavirus disease 2019 (COVID …
(SARS), middle east respiratory syndrome (MERS) and coronavirus disease 2019 (COVID …
Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis
Metabolic-associated fatty liver disease (MAFLD) and its potential impact on the severity of
COVID-19 have gained significant attention during the pandemic. This review aimed to …
COVID-19 have gained significant attention during the pandemic. This review aimed to …
Association of nonalcoholic fatty liver disease with COVID-19 severity and pulmonary thrombosis: CovidFAT, a prospective, observational cohort study
N Vrsaljko, L Samadan, K Viskovic… - Open forum …, 2022 - academic.oup.com
Background Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease
associated with systemic changes in immune response, which might be associated with …
associated with systemic changes in immune response, which might be associated with …
[HTML][HTML] Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?
CG Dietrich, A Geier, U Merle - World journal of gastroenterology, 2023 - ncbi.nlm.nih.gov
The pandemics of coronavirus disease 2019 (COVID-19) and non-alcoholic fatty liver
disease (NAFLD) coexist. Elevated liver function tests are frequent in COVID-19 and may …
disease (NAFLD) coexist. Elevated liver function tests are frequent in COVID-19 and may …
The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence
The global population is currently experiencing the impact of the SARS-CoV-2 coronavirus,
which has caused the Coronavirus Disease 2019 (COVID-19) pandemic. With our profound …
which has caused the Coronavirus Disease 2019 (COVID-19) pandemic. With our profound …
[HTML][HTML] COVID-19 and liver injury: An ongoing challenge
I Papagiouvanni, SC Kotoulas, A Pataka… - World Journal of …, 2023 - ncbi.nlm.nih.gov
The new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was
identified in December 2019, in Wuhan, China. The virus was rapidly spread worldwide …
identified in December 2019, in Wuhan, China. The virus was rapidly spread worldwide …